NCT01270724: A trial that was reported late by Nationwide Children's Hospital
This trial has reported, although it was 1363 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01270724 |
|---|---|
| Title | A Phase II Clinical Trial of Induction Chemotherapy Regimen Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) Followed by a Single Cycle of High Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Rescue (AuHSCR) for Patients With Recurrent or Progressive Intracranial Germ Cell Tumors |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Aug. 31, 2010 |
| Completion date | Oct. 23, 2019 |
| Required reporting date | Oct. 22, 2020, midnight |
| Actual reporting date | July 17, 2024 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 1363 |